外科学(一般・消化器)

Medicine & Life Sciences

1. Esophageal Neoplasms 100%
2. Esophagectomy 90%
3. Neoplasms 64%
4. Liver Transplantation 61%
5. Esophageal Squamous Cell Carcinoma 55%
6. Neoplasm Metastasis 55%
7. Liver 54%
8. Stomach Neoplasms 52%
9. Colorectal Neoplasms 50%
10. Recurrence 48%
11. Survival 46%
12. Japan 45%
13. Living Donors 42%
14. Lymph Nodes 37%
15. Pancreatic Neoplasms 31%
16. Transplants 31%
17. Gastrectomy 30%
18. Hepatocellular Carcinoma 30%
19. Drug Therapy 29%
20. Breast Neoplasms 27%
21. Therapeutics 26%
22. Aneurysm 24%
23. Laparoscopy 23%
24. Adenocarcinoma 22%
25. Rectal Neoplasms 22%
26. Postoperative Complications 21%
27. Neoadjuvant Therapy 21%
28. Hepatectomy 20%
29. Acute Liver Failure 20%
30. Chemoradiotherapy 19%
31. Fluorouracil 19%
32. Anastomotic Leak 19%
33. Lymph Node Excision 19%
34. Colonic Neoplasms 19%
35. Stomach 17%
36. Cholangiocarcinoma 17%
37. Retrospective Studies 17%
38. Swine 16%
39. Transplantation 15%
40. Confidence Intervals 15%
41. Artificial Intelligence 15%
42. Colorectal Surgery 15%
43. Surgical Wound Infection 15%
44. Cisplatin 15%
45. Systematic Reviews 15%
46. Stents 14%
47. Carcinoma 14%
48. Incidence 14%
49. Iliac Artery 13%
50. Propensity Score 13%
51. Dissection 13%
52. Databases 13%
53. Pancreaticoduodenectomy 12%
54. Tumor Burden 12%
55. Tissue Donors 12%
56. Abdominal Aortic Aneurysm 12%
57. Sentinel Lymph Node 12%
58. Mortality 11%
59. Multivariate Analysis 11%
60. Safety 11%
61. Meta-Analysis 11%
62. Tomography 11%
63. Survival Rate 11%
64. Disease-Free Survival 11%
65. Ulcerative Colitis 11%
66. Cohort Studies 11%
67. Pancreatectomy 11%
68. Pneumonia 11%
69. Adjuvant Chemotherapy 11%
70. Mesenchymal Stem Cells 10%
71. Thorax 10%
72. Biomarkers 10%
73. Portal Vein 10%
74. Laparoscopic Cholecystectomy 10%
75. Multicenter Studies 9%
76. Liver Failure 9%
77. Pancreas 9%
78. Reperfusion Injury 9%
79. Surgeons 9%
80. Serum 9%
81. Colectomy 9%
82. Hepatocytes 9%
83. Odds Ratio 8%
84. Drainage 8%
85. Lung 8%
86. Enteral Nutrition 8%
87. Equipment and Supplies 8%
88. Extremities 8%
89. Hepatic Veins 8%
90. Area Under Curve 8%
91. Randomized Controlled Trials 8%
92. Blood Vessels 8%
93. Gallbladder 8%
94. olanexidine 8%
95. Prospective Studies 8%
96. Tokyo 8%
97. Network Meta-Analysis 8%
98. human ERBB2 protein 8%
99. ErbB Receptors 8%
100. Uterus 8%